DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,701 | +9.2% | 2,016 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,632 | -49.6% | 2,016 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $23,075 | -31.9% | 2,249 | +11.0% | 0.00% | -50.0% |
| Q3 2022 | $33,891 | +19.4% | 2,027 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,378 | -13.3% | 2,027 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $32,736 | -81.0% | 2,027 | -74.8% | 0.00% | -50.0% |
| Q4 2021 | $172,308 | – | 8,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |